Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Chylek who wrote (384)	2/6/1997 9:30:00 AM
From: scaram(o)uche	of 2742

Nothing important (or new, I guess), but IMNX released earnings after the close yesterday. Here's what CIST looked like......... *********** Immunex Reports 1996 Year End Results Increased Development Investment Yields Approvals for Novantrone(R) and Leukine Liquid(TM); New Program for Enbrel(TM) in Rheumatoid Arthritis SEATTLE, Feb. 5 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) today reported a net loss for the quarter ended December 31, 1996 of $30.5 million, or 77 cents per share, which includes a one-time charge of $18.1 million related to a legal settlement. (snip) ************************************************** I guess 21 million is 18.1 when time (the payments over four years) is factored in? Cheers! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next